China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.
Here you can find out where Chinese investors have been investing their money in at around 5pm each workday.
|Company||Round||Amount||Lead Investor||Participants||Company Intro|
|XpressBees||Strategic financing||US$100 million||Alibaba Group||XpressBees is a Pune, India-based e-commerce logistics company, providing same/next day delivery, cash on delivery and other customized logistics solutions in India.|
|Lizhi.FM||Series D||US$50 million||Orchid Asia Group||Evolution Media China||Lizhi.FM is a Chinese radio mobile app developer and podcast sharing platform.|
|Guomai Media||Series B, Series C||US$45.7M||IDG Capital, Bona Film Group Ltd.||Aqua Ventures, HG Capital, Matrix Partners China||Guomai publishes multi-media cultural products for the new middle class in the categories of literature, history, science and religion.|
|AISEC||Strategic financing||US$15 million||Tencent Holdings||AISEC is a Chinese network security service provider. Its core products include security detection system AIScanner and intrusion detection system WebIDS.|
|Yimi Station||Pre-A||Tens of millions of RMB||undisclosed||Yimi Station is a Shenzhen-based smart food ordering platform. Users can place orders online and food will be delivered to a nearby smart food box, which has automatic temperate control and can be opened with QR code.
|Cihon.cn||Series B||undisclosed||Marathon Venture Partners, Dongfeng Asset Management Co., Ltd||Cihon is a Beijing-based car data provider for carmakers, car insurers and other third-party service providers.
|Huada Empyrean Software||Strategic financing||US$15 million||National Small and Medium-size Enterprises Development Fund (Shenzhen Guozhong Venture Capital Management Co., Ltd)||China Electronics Corporation, Shenzhen Venture Capital Group||Huada Empyrean Software is a Beijing-based electronic design automation (EDA) software developer and solution provider.|
|Frontier Biotech||Series C||US$48 million||Beijing Huaxin Century Investment Group Co., Ltd||Shenzhen Capital Group Co., Ltd, Efung Capital||Frontier Biotech is a Nanjing-based clinical stage pharmaceutical company. It has developed a long-acting peptide drug discovery and development platform that could potentially transform any peptide drug into long-acting agent.|